MIT graduate engineering and business programs ranked highly by U.S. News for 2026-27
Graduate engineering program is No. 1 in the nation; MIT Sloan is No. 6.
Department
Biological Engineering
Building the blocks of life
Computational biologist Sergei Kotelnikov is working to develop new methods in protein modeling as part of the School of Science Dean’s Postdoctoral Fellowship.
Study reveals why some cancer therapies don’t work for all patients
A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.
Improving cartilage repair through cell therapy
SMART breakthrough offers a promising pathway toward improved manufacturing of high‑quality cells for regenerative therapies to treat joint diseases.
MIT School of Engineering faculty receive awards in fall 2025
Faculty members and researchers were honored in recognition of their scholarship, service, and overall excellence.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators
Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
Bridging science and society in the emerging bioeconomy
In STS.059 (The Bioeconomy and Society), students explore the social and political factors at work in the biology, biotech, and biological engineering sectors.
MIT community members elected to the National Academy of Engineering for 2026
Seven faculty members, along with 12 additional alumni, are honored for significant contributions to engineering research, practice, and education.
Using synthetic biology and AI to address global antimicrobial resistance threat
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
New vaccine platform promotes rare protective B cells
Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.
3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs
Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
Katie Spivakovsky wins 2026 Churchill Scholarship
The MIT senior will pursue a master’s degree at Cambridge University in the U.K. this fall.
New tissue models could help researchers develop drugs for liver disease
Two models more accurately replicate the physiology of the liver, offering a new way to test treatments for fat buildup.
Designing the future of metabolic health through tissue-selective drug delivery
Founded by three MIT alumni, Gensaic uses AI-guided protein design to deliver RNA and other therapeutic molecules to specific cells or areas of the body.
Bryan Bryson: Engineering solutions to the tough problem of tuberculosis
By analyzing how Myobacterium tuberculosis interacts with the immune system, the associate professor hopes to find new vaccine targets to help eliminate the disease.